- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01824875
Temozolomide med eller utan capecitabin vid behandling av patienter med avancerade pankreatiska neuroendokrina tumörer
En randomiserad fas II-studie av temozolomid eller temozolomid och capecitabin hos patienter med avancerade pankreatiska neuroendokrina tumörer
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 2
Kontakter och platser
Studieorter
-
-
California
-
Anaheim, California, Förenta staterna, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Förenta staterna, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Förenta staterna, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Förenta staterna, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Förenta staterna, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Förenta staterna, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Förenta staterna, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Förenta staterna, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Förenta staterna, 93720
- Kaiser Permanente
-
Harbor City, California, Förenta staterna, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Förenta staterna, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Förenta staterna, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Förenta staterna, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Förenta staterna, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Förenta staterna, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Förenta staterna, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Förenta staterna, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Förenta staterna, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Förenta staterna, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Förenta staterna, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Förenta staterna, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Förenta staterna, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Förenta staterna, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Förenta staterna, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Förenta staterna, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Förenta staterna, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Förenta staterna, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Förenta staterna, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Förenta staterna, 92120
- Kaiser Permanente
-
San Francisco, California, Förenta staterna, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Förenta staterna, 94118
- California Pacific Medical Center
-
San Francisco, California, Förenta staterna, 94115
- UCSF-Mount Zion
-
San Jose, California, Förenta staterna, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Förenta staterna, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Förenta staterna, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Förenta staterna, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Förenta staterna, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Förenta staterna, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Förenta staterna, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Förenta staterna, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Förenta staterna, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Förenta staterna, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Förenta staterna, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Förenta staterna, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Förenta staterna, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Förenta staterna, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Förenta staterna, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Förenta staterna, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Förenta staterna, 19958
- Beebe Medical Center
-
Newark, Delaware, Förenta staterna, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Förenta staterna, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Förenta staterna, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Förenta staterna, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Förenta staterna, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Förenta staterna, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Förenta staterna, 19971
- Beebe Health Campus
-
Seaford, Delaware, Förenta staterna, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Förenta staterna, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Förenta staterna, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Förenta staterna, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Förenta staterna, 32803
- Florida Hospital
-
Tampa, Florida, Förenta staterna, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Förenta staterna, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Förenta staterna, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Förenta staterna, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Förenta staterna, 96813
- University of Hawaii
-
Honolulu, Hawaii, Förenta staterna, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Förenta staterna, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Förenta staterna, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Förenta staterna, 96734
- Castle Medical Center
-
Lihue, Hawaii, Förenta staterna, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Förenta staterna, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Förenta staterna, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Förenta staterna, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Förenta staterna, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Förenta staterna, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Förenta staterna, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Förenta staterna, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Förenta staterna, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Förenta staterna, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Förenta staterna, 60611
- Northwestern University
-
Chicago, Illinois, Förenta staterna, 60612
- University of Illinois
-
Decatur, Illinois, Förenta staterna, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Förenta staterna, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Förenta staterna, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Förenta staterna, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Förenta staterna, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Förenta staterna, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Förenta staterna, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Förenta staterna, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Förenta staterna, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Förenta staterna, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Förenta staterna, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Förenta staterna, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Förenta staterna, 60153
- Loyola University Medical Center
-
Moline, Illinois, Förenta staterna, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Förenta staterna, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Förenta staterna, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Förenta staterna, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Förenta staterna, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Förenta staterna, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Förenta staterna, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Förenta staterna, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Förenta staterna, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Förenta staterna, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Förenta staterna, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Förenta staterna, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Förenta staterna, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Förenta staterna, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Förenta staterna, 61614
- Proctor Hospital
-
Peoria, Illinois, Förenta staterna, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Förenta staterna, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Förenta staterna, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Förenta staterna, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Förenta staterna, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Förenta staterna, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Förenta staterna, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Förenta staterna, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Förenta staterna, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Förenta staterna, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Förenta staterna, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Förenta staterna, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Förenta staterna, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Förenta staterna, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Förenta staterna, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Förenta staterna, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Förenta staterna, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Förenta staterna, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Förenta staterna, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Förenta staterna, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Förenta staterna, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Förenta staterna, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Förenta staterna, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Förenta staterna, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Förenta staterna, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Förenta staterna, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Förenta staterna, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Förenta staterna, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Förenta staterna, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Förenta staterna, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Förenta staterna, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Förenta staterna, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Förenta staterna, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Förenta staterna, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Förenta staterna, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Förenta staterna, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Förenta staterna, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Förenta staterna, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Förenta staterna, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Förenta staterna, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Förenta staterna, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Förenta staterna, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Förenta staterna, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Förenta staterna, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Förenta staterna, 67208
- Associates In Womens Health
-
Wichita, Kansas, Förenta staterna, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Förenta staterna, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Förenta staterna, 67214
- Wichita CCOP
-
Winfield, Kansas, Förenta staterna, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Förenta staterna, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Förenta staterna, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Förenta staterna, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Förenta staterna, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Förenta staterna, 49221
- Bixby Medical Center
-
Adrian, Michigan, Förenta staterna, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Förenta staterna, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Förenta staterna, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Förenta staterna, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Förenta staterna, 48124
- Oakwood Hospital
-
Detroit, Michigan, Förenta staterna, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Förenta staterna, 48502
- Hurley Medical Center
-
Flint, Michigan, Förenta staterna, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Förenta staterna, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Förenta staterna, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Förenta staterna, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Förenta staterna, 49001
- Borgess Medical Center
-
Lansing, Michigan, Förenta staterna, 48912
- Sparrow Hospital
-
Livonia, Michigan, Förenta staterna, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Förenta staterna, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Förenta staterna, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Förenta staterna, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Förenta staterna, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Förenta staterna, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Förenta staterna, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Förenta staterna, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Förenta staterna, 55433
- Mercy Hospital
-
Edina, Minnesota, Förenta staterna, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Förenta staterna, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Förenta staterna, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Förenta staterna, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Förenta staterna, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Förenta staterna, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Förenta staterna, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Förenta staterna, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Förenta staterna, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Förenta staterna, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Förenta staterna, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Förenta staterna, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Förenta staterna, 55102
- United Hospital
-
Shakopee, Minnesota, Förenta staterna, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Förenta staterna, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Förenta staterna, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Förenta staterna, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Förenta staterna, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Förenta staterna, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Förenta staterna, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Förenta staterna, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Förenta staterna, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Förenta staterna, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Förenta staterna, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Förenta staterna, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Förenta staterna, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Förenta staterna, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Förenta staterna, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Förenta staterna, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Förenta staterna, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Förenta staterna, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Förenta staterna, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Förenta staterna, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Förenta staterna, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Förenta staterna, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Förenta staterna, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Förenta staterna, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Förenta staterna, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Förenta staterna, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Förenta staterna, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Förenta staterna, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Förenta staterna, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Förenta staterna, 14642
- University of Rochester
-
The Bronx, New York, Förenta staterna, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Förenta staterna, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Förenta staterna, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Förenta staterna, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Förenta staterna, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Förenta staterna, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Förenta staterna, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Förenta staterna, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Förenta staterna, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Förenta staterna, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Förenta staterna, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Förenta staterna, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Förenta staterna, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Förenta staterna, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Förenta staterna, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Förenta staterna, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Förenta staterna, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Förenta staterna, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Förenta staterna, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Förenta staterna, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Förenta staterna, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Förenta staterna, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Förenta staterna, 43228
- Doctors Hospital
-
Columbus, Ohio, Förenta staterna, 43215
- Grant Medical Center
-
Columbus, Ohio, Förenta staterna, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Förenta staterna, 43215
- Columbus CCOP
-
Dayton, Ohio, Förenta staterna, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Förenta staterna, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Förenta staterna, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Förenta staterna, 45405
- Grandview Hospital
-
Dayton, Ohio, Förenta staterna, 45420
- Dayton CCOP
-
Delaware, Ohio, Förenta staterna, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Förenta staterna, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Förenta staterna, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Förenta staterna, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Förenta staterna, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Förenta staterna, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Förenta staterna, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Förenta staterna, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Förenta staterna, 45331
- Wayne Hospital
-
Independence, Ohio, Förenta staterna, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Förenta staterna, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Förenta staterna, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Förenta staterna, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Förenta staterna, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Förenta staterna, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Förenta staterna, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Förenta staterna, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Förenta staterna, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Förenta staterna, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Förenta staterna, 43050
- Knox Community Hospital
-
Newark, Ohio, Förenta staterna, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Förenta staterna, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Förenta staterna, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Förenta staterna, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Förenta staterna, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Förenta staterna, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Förenta staterna, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Förenta staterna, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Förenta staterna, 43560
- Flower Hospital
-
Tiffin, Ohio, Förenta staterna, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Förenta staterna, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Förenta staterna, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Förenta staterna, 43614
- University of Toledo
-
Toledo, Ohio, Förenta staterna, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Förenta staterna, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Förenta staterna, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Förenta staterna, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Förenta staterna, 43567
- Fulton County Health Center
-
Westerville, Ohio, Förenta staterna, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Förenta staterna, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Förenta staterna, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Förenta staterna, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Förenta staterna, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Förenta staterna, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Förenta staterna, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Förenta staterna, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Förenta staterna, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Förenta staterna, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Förenta staterna, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Förenta staterna, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Förenta staterna, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Förenta staterna, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Förenta staterna, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Förenta staterna, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Förenta staterna, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Förenta staterna, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Förenta staterna, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Förenta staterna, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Förenta staterna, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Förenta staterna, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Förenta staterna, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Förenta staterna, 54017
- Cancer Center of Western Wisconsin
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andra namn:
|
|
Experimentell: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andra namn:
Given PO
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Progression-free Survival
Tidsram: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Proportion of Patients With Response
Tidsram: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Tidsram: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Tidsram: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Tidsram: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Beräknad)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Sjukdomar i det endokrina systemet
- Neoplasmer efter plats
- Neoplasmer
- Neoplasmer efter histologisk typ
- Neoplasmer i matsmältningssystemet
- Matsmältningssystemets sjukdomar
- Neoplasmer i endokrina körtel
- Bukspottkörtelsjukdomar
- Neoplasmer, körtel och epitel
- Adenocarcinom
- Adenom
- Carcinom
- Neuroektodermala tumörer
- Neoplasmer, könsceller och embryonala
- Neuroendokrina tumörer
- Karcinom, neuroendokrina
- Pankreatiska neoplasmer
- Adenom, öcell
- Karcinom, öcell
- Gastrinom
- Insulinom
- Glukagonom
- Somatostatinom
- Organiska kemikalier
- Heterocykliska föreningar, 1-ring
- Heterocykliska föreningar
- Azoler
- Nukleinsyror, nukleotider och nukleosider
- Dacarbazin
- Triazenes
- Imidazoler
- Deoxycytidin
- Cytidin
- Pyrimidin nukleosider
- Pyrimidiner
- Nukleosider
- Uracil
- Pyrimidinoner
- Deoxyribonukleosider
- Fluorouracil
- Temozolomid
- Capecitabin
Andra studie-ID-nummer
- E2211
- U10CA180820 (U.S.S. NIH-anslag/kontrakt)
- U10CA021115 (U.S.S. NIH-anslag/kontrakt)
- E2211 (Annan identifierare: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .